Jay A. Salpekar

1.8k total citations
44 papers, 1.1k citations indexed

About

Jay A. Salpekar is a scholar working on Psychiatry and Mental health, Pediatrics, Perinatology and Child Health and Clinical Psychology. According to data from OpenAlex, Jay A. Salpekar has authored 44 papers receiving a total of 1.1k indexed citations (citations by other indexed papers that have themselves been cited), including 38 papers in Psychiatry and Mental health, 18 papers in Pediatrics, Perinatology and Child Health and 9 papers in Clinical Psychology. Recurrent topics in Jay A. Salpekar's work include Epilepsy research and treatment (28 papers), Pharmacological Effects and Toxicity Studies (15 papers) and Attention Deficit Hyperactivity Disorder (9 papers). Jay A. Salpekar is often cited by papers focused on Epilepsy research and treatment (28 papers), Pharmacological Effects and Toxicity Studies (15 papers) and Attention Deficit Hyperactivity Disorder (9 papers). Jay A. Salpekar collaborates with scholars based in United States, United Kingdom and Saudi Arabia. Jay A. Salpekar's co-authors include Jamie Maguire, Marco Mula, Rochelle Caplan, Margaret D. Weiss, Jana E. Jones, Sigita Plioplys, Laurie M. Douglass, Joan K. Austin, Andrés M. Kanner and John J. Barry and has published in prestigious journals such as Neurology, Journal of the American Academy of Child & Adolescent Psychiatry and Epilepsia.

In The Last Decade

Jay A. Salpekar

39 papers receiving 1.1k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Jay A. Salpekar United States 20 865 516 209 172 141 44 1.1k
Gerardo Maria de Araújo Filho Brazil 23 1.3k 1.5× 630 1.2× 328 1.6× 153 0.9× 319 2.3× 108 1.6k
Dimitrios Kontis Greece 17 415 0.5× 199 0.4× 150 0.7× 191 1.1× 194 1.4× 35 899
Cristian Zeni Brazil 24 1.1k 1.3× 155 0.3× 170 0.8× 349 2.0× 350 2.5× 72 1.6k
Grazia Maria Giovanna Pastorino Italy 18 368 0.4× 222 0.4× 124 0.6× 134 0.8× 200 1.4× 61 758
Avi Reichenberg United States 14 605 0.7× 135 0.3× 188 0.9× 234 1.4× 320 2.3× 28 1.3k
Martina Balestri Italy 17 336 0.4× 138 0.3× 103 0.5× 132 0.8× 87 0.6× 34 748
Anna Mané Spain 18 583 0.7× 76 0.1× 89 0.4× 149 0.9× 222 1.6× 70 902
T A Ketter United States 11 680 0.8× 234 0.5× 124 0.6× 89 0.5× 261 1.9× 15 920
Diego Luiz Rovaris Brazil 18 554 0.6× 72 0.1× 130 0.6× 161 0.9× 329 2.3× 72 1.1k
M. Trimble United Kingdom 18 530 0.6× 274 0.5× 212 1.0× 284 1.7× 294 2.1× 27 1.1k

Countries citing papers authored by Jay A. Salpekar

Since Specialization
Citations

This map shows the geographic impact of Jay A. Salpekar's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jay A. Salpekar with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jay A. Salpekar more than expected).

Fields of papers citing papers by Jay A. Salpekar

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Jay A. Salpekar. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jay A. Salpekar. The network helps show where Jay A. Salpekar may publish in the future.

Co-authorship network of co-authors of Jay A. Salpekar

This figure shows the co-authorship network connecting the top 25 collaborators of Jay A. Salpekar. A scholar is included among the top collaborators of Jay A. Salpekar based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Jay A. Salpekar. Jay A. Salpekar is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Salpekar, Jay A., Marco Mula, Niruj Agrawal, & Kenneth R. Kaufman. (2025). Neuropsychiatry as a paradigm propelling neurology and psychiatry into the future. BJPsych Open. 11(2). e38–e38. 1 indexed citations
2.
Salpekar, Jay A. & Lawrence David Scahill. (2024). Psychopharmacology Management in Autism Spectrum Disorder. Pediatric Clinics of North America. 71(2). 283–299. 3 indexed citations
3.
Salpekar, Jay A., et al.. (2024). Key Treatment Issues for Epilepsy in the Context of Autism Spectrum Disorder. Current Treatment Options in Neurology. 26(10). 433–440.
4.
Salpekar, Jay A., et al.. (2024). Anxiety and school avoidance in an 8-year-old child with epilepsy. Epilepsy & Behavior Reports. 26. 100659–100659. 1 indexed citations
5.
Ryan, Matthew, Doris Lin, Stacy J. Suskauer, et al.. (2022). Cannabidiol Treatment for Neurological, Cognitive, and Psychiatric Symptoms in Sturge-Weber Syndrome. Pediatric Neurology. 139. 24–34. 11 indexed citations
6.
Maguire, Jamie, et al.. (2021). Hypothalamic-pituitary-adrenal axis targets for the treatment of epilepsy. Neuroscience Letters. 746. 135618–135618. 30 indexed citations
7.
Strickland, Justin C., et al.. (2021). Cross-sectional and longitudinal evaluation of cannabidiol (CBD) product use and health among people with epilepsy. Epilepsy & Behavior. 122. 108205–108205. 12 indexed citations
9.
Salpekar, Jay A. & Marco Mula. (2018). Common psychiatric comorbidities in epilepsy: How big of a problem is it?. Epilepsy & Behavior. 98(Pt B). 293–297. 86 indexed citations
10.
Salpekar, Jay A., et al.. (2018). Using Lithium in Children and Adolescents with Bipolar Disorder: Efficacy, Tolerability, and Practical Considerations. Pediatric Drugs. 20(4). 303–314. 9 indexed citations
11.
Salpekar, Jay A.. (2017). Neuropsychiatric effects of epilepsy in developmental disorders. Current Opinion in Psychiatry. 31(2). 109–115. 6 indexed citations
12.
Salpekar, Jay A., Paramjit T. Joshi, David Axelson, et al.. (2015). Depression and Suicidality Outcomes in the Treatment of Early Age Mania Study. Journal of the American Academy of Child & Adolescent Psychiatry. 54(12). 999–1007.e4. 19 indexed citations
13.
Salpekar, Jay A., et al.. (2014). Key Issues in Addressing the Comorbidity of Attention Deficit Hyperactivity Disorder and Pediatric Epilepsy. Epilepsy & Behavior. 37. 310–315. 36 indexed citations
14.
Maguire, Jamie & Jay A. Salpekar. (2012). Stress, seizures, and hypothalamic–pituitary–adrenal axis targets for the treatment of epilepsy. Epilepsy & Behavior. 26(3). 352–362. 129 indexed citations
15.
Weiss, Margaret D. & Jay A. Salpekar. (2010). Sleep Problems in the Child with Attention-Deficit Hyperactivity Disorder. CNS Drugs. 24(10). 811–828. 69 indexed citations
16.
Salpekar, Jay A., et al.. (2008). Parenting stress and childhood epilepsy: The impact of depression, learning, and seizure-related factors. Epilepsy & Behavior. 13(1). 109–114. 85 indexed citations
17.
Barry, John J., Alan B. Ettinger, Frank Gilliam, et al.. (2008). Consensus statement: The evaluation and treatment of people with epilepsy and affective disorders. Epilepsy & Behavior. 13. S1–S29. 174 indexed citations
18.
Plioplys, Sigita, Miya R. Asato, Brenda Bursch, et al.. (2007). Multidisciplinary Management of Pediatric Nonepileptic Seizures. Journal of the American Academy of Child & Adolescent Psychiatry. 46(11). 1491–1495. 18 indexed citations
19.
Salpekar, Jay A. & David W. Dunn. (2007). Psychiatric and Psychosocial Consequences of Pediatric Epilepsy. Seminars in Pediatric Neurology. 14(4). 181–188. 22 indexed citations
20.
Berl, Madison M., Jay A. Salpekar, Phillip L. Pearl, et al.. (2006). The benefits of a camp designed for children with epilepsy: Evaluating adaptive behaviors over 3 years. Epilepsy & Behavior. 10(1). 170–178. 29 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026